Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/24/2025 | $5.00 | Buy | Maxim Group |
NT 10-K - VSEE HEALTH, INC. (0001864531) (Filer)
8-K - VSEE HEALTH, INC. (0001864531) (Filer)
8-K - VSEE HEALTH, INC. (0001864531) (Filer)
ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth
ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)
SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)
SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)
Strategic Hospital Pilots and Research Partnerships Position Company for Scalable Growth in $787B Digital Health Market VSee Health, Inc. (NASDAQ:VSEE), a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform, has completed development of its Telenursing Robotics solution—an AI-driven platform designed to automate routine nursing tasks and reduce labor costs. With nursing expenses representing approximately 60% of hospital operating budgets, this innovation directly targets one of the most pressing cost challenges in healthcare. Initial modeling suggests hospitals deploying VSee's solution could re
Game-Changing AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare Market VSee Health, Inc. (NASDAQ:VSEE): Major Clients Include NASA, U.S. Department of Health and Human Services, McKesson, DaVita and the Entire Nation of Qatar HARRISON TOWNSHIP, N.J., April 2, 2025 /PRNewswire/ -- The healthcare industry is undergoing a significant transformation, and VSee Health, Inc. (NASDAQ:VSEE) is at the forefront, pioneering AI-driven telehealth solutions that are revolutionizing patient care. As a leader in digital health technology, VSEE is redefining the $787 billion digital healthcare market with cutting-edge innovations, major partnerships, and a rapidly growing client base that
Company Accomplishments, Initiatives and Strong AI Powered Product Pipeline Setting a Path to Record Success in 2025 VSee Health (NASDAQ:VSEE), a rapidly growing leader in AI-powered telehealth, is redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by more than 1,000 clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health accelerates telehealth adoption by enabling seamless, scalable and secure digital health solutions across hospitals, governments, and enterprise organizations. Today, VSee Health has issued the following letter to shareholders from Co-C
Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00